Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Apr 15;101(8):1687–1692. doi: 10.1172/JCI1089

The HPV-activating cellular transcription factor Brn-3a is overexpressed in CIN3 cervical lesions.

D Ndisdang 1, P J Morris 1, C Chapman 1, L Ho 1, A Singer 1, D S Latchman 1
PMCID: PMC508750  PMID: 9541499

Abstract

The cervical cellular transcription factors Brn-3a and Brn-3b have antagonistic effects on transcription of the human papilloma virus types 16 and 18 E6 and E7 oncogenes, with Brn-3a activating expression and Brn-3b repressing it. We therefore measured expression of Brn-3a and Brn-3b mRNAs in biopsies from 16 women with no detectable cervical abnormality, and in 14 women with cervical intraepithelial neoplasia grade 3 (CIN3) lesions. Although the mean level of Brn-3b expression was similar in both groups, the mean level of Brn-3a expression was over 300-fold higher in the CIN3 samples when compared with normals. Elevated expression of Brn-3a was also detected in 16 histologically normal regions of the cervix adjacent to the CIN3 lesions, indicating that elevation of Brn-3a levels is not confined to the lesion in women with CIN3, and is thus not a consequence of the oncogenic process. The elevated levels of Brn-3a in the CIN3 patient samples, together with the activating effect of Brn-3a on HPV-16 and -18 oncogene expression, suggest that induction of this factor is involved in activating HPV-16 and -18 oncogene expression in the cervix, and hence in the production of cervical cancers induced by HPV.

Full Text

The Full Text of this article is available as a PDF (179.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Begbie J. L., Wood J. N., Anderson P. N., Latchman D. S. Specific up-regulation of the POU domain transcription factor Oct-2 following axotomy. Neurosci Lett. 1996 Apr 5;207(3):183–186. doi: 10.1016/0304-3940(96)12514-3. [DOI] [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  3. Budhram-Mahadeo V., Lillycrop K. A., Latchman D. S. The levels of the antagonistic POU family transcription factors Brn-3a and Brn-3b in neuronal cells are regulated in opposite directions by serum growth factors. Neurosci Lett. 1995 Feb 6;185(1):48–51. doi: 10.1016/0304-3940(94)11222-5. [DOI] [PubMed] [Google Scholar]
  4. Budhram-Mahadeo V., Theil T., Morris P. J., Lillycrop K. A., Moroy T., Latchman D. S. The DNA target site for the Brn-3 POU family transcription factors can confer responsiveness to cyclic AMP and removal of serum in neuronal cells. Nucleic Acids Res. 1994 Aug 11;22(15):3092–3098. doi: 10.1093/nar/22.15.3092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chan W. K., Chong T., Bernard H. U., Klock G. Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites. Nucleic Acids Res. 1990 Feb 25;18(4):763–769. doi: 10.1093/nar/18.4.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chan W. K., Klock G., Bernard H. U. Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol. 1989 Aug;63(8):3261–3269. doi: 10.1128/jvi.63.8.3261-3269.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  8. Cox M. F., Meanwell C. A., Maitland N. J., Blackledge G., Scully C., Jordan J. A. Human papillomavirus type-16 homologous DNA in normal human ectocervix. Lancet. 1986 Jul 19;2(8499):157–158. doi: 10.1016/s0140-6736(86)91965-3. [DOI] [PubMed] [Google Scholar]
  9. Cripe T. P., Haugen T. H., Turk J. P., Tabatabai F., Schmid P. G., 3rd, Dürst M., Gissmann L., Roman A., Turek L. P. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. EMBO J. 1987 Dec 1;6(12):3745–3753. doi: 10.1002/j.1460-2075.1987.tb02709.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dent C. L., McIndoe G. A., Latchman D. S. The constitutively expressed octamer binding protein OTF-1 and a novel octamer binding protein expressed specifically in cervical cells bind to an octamer-related sequence in the human papillomavirus 16 enhancer. Nucleic Acids Res. 1991 Aug 25;19(16):4531–4535. doi: 10.1093/nar/19.16.4531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dhillon V. B., McCallum S., Norton P., Twomey B. M., Erkeller-Yuksel F., Lydyard P., Isenberg D. A., Latchman D. S. Differential heat shock protein overexpression and its clinical relevance in systemic lupus erythematosus. Ann Rheum Dis. 1993 Jun;52(6):436–442. doi: 10.1136/ard.52.6.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dürst M., Gissmann L., Ikenberg H., zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3812–3815. doi: 10.1073/pnas.80.12.3812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gerrero M. R., McEvilly R. J., Turner E., Lin C. R., O'Connell S., Jenne K. J., Hobbs M. V., Rosenfeld M. G. Brn-3.0: a POU-domain protein expressed in the sensory, immune, and endocrine systems that functions on elements distinct from known octamer motifs. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10841–10845. doi: 10.1073/pnas.90.22.10841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gloss B., Bernard H. U., Seedorf K., Klock G. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J. 1987 Dec 1;6(12):3735–3743. doi: 10.1002/j.1460-2075.1987.tb02708.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gloss B., Yeo-Gloss M., Meisterenst M., Rogge L., Winnacker E. L., Bernard H. U. Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res. 1989 May 11;17(9):3519–3533. doi: 10.1093/nar/17.9.3519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ho L., Terry G., Mansell B., Butler B., Singer A. Detection of DNA and E7 transcripts of human papillomavirus types 16, 18, 31 and 33, TGF beta and GM-CSF transcripts in cervical cancers and precancers. Arch Virol. 1994;139(1-2):79–85. doi: 10.1007/BF01309455. [DOI] [PubMed] [Google Scholar]
  17. Kendall G., Brar-Rai A., Ensor E., Winter J., Wood J. N., Latchman D. S. Nerve growth factor induces the Oct-2 transcription factor in sensory neurons with the kinetics of an immediate-early gene. J Neurosci Res. 1995 Feb 1;40(2):169–176. doi: 10.1002/jnr.490400205. [DOI] [PubMed] [Google Scholar]
  18. Lillycrop K. A., Budrahan V. S., Lakin N. D., Terrenghi G., Wood J. N., Polak J. M., Latchman D. S. A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells. Nucleic Acids Res. 1992 Oct 11;20(19):5093–5096. doi: 10.1093/nar/20.19.5093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Meanwell C. A., Cox M. F., Blackledge G., Maitland N. J. HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behaviour of cervical neoplasia. Lancet. 1987 Mar 28;1(8535):703–707. doi: 10.1016/s0140-6736(87)90353-9. [DOI] [PubMed] [Google Scholar]
  20. Morris P. J., Dent C. L., Ring C. J., Latchman D. S. The octamer binding site in the HPV16 regulatory region produces opposite effects on gene expression in cervical and non-cervical cells. Nucleic Acids Res. 1993 Feb 25;21(4):1019–1023. doi: 10.1093/nar/21.4.1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Morris P. J., Theil T., Ring C. J., Lillycrop K. A., Moroy T., Latchman D. S. The opposite and antagonistic effects of the closely related POU family transcription factors Brn-3a and Brn-3b on the activity of a target promoter are dependent on differences in the POU domain. Mol Cell Biol. 1994 Oct;14(10):6907–6914. doi: 10.1128/mcb.14.10.6907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nakshatri H., Pater M. M., Pater A. Ubiquitous and cell-type-specific protein interactions with human papillomavirus type 16 and type 18 enhancers. Virology. 1990 Sep;178(1):92–103. doi: 10.1016/0042-6822(90)90382-2. [DOI] [PubMed] [Google Scholar]
  23. Schiffman M. H., Bauer H. M., Hoover R. N., Glass A. G., Cadell D. M., Rush B. B., Scott D. R., Sherman M. E., Kurman R. J., Wacholder S. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993 Jun 16;85(12):958–964. doi: 10.1093/jnci/85.12.958. [DOI] [PubMed] [Google Scholar]
  24. Smith M. D., Dawson S. J., Latchman D. S. The Brn-3a transcription factor induces neuronal process outgrowth and the coordinate expression of genes encoding synaptic proteins. Mol Cell Biol. 1997 Jan;17(1):345–354. doi: 10.1128/mcb.17.1.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Theil T., McLean-Hunter S., Zörnig M., Möröy T. Mouse Brn-3 family of POU transcription factors: a new aminoterminal domain is crucial for the oncogenic activity of Brn-3a. Nucleic Acids Res. 1993 Dec 25;21(25):5921–5929. doi: 10.1093/nar/21.25.5921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Turner E. E., Jenne K. J., Rosenfeld M. G. Brn-3.2: a Brn-3-related transcription factor with distinctive central nervous system expression and regulation by retinoic acid. Neuron. 1994 Jan;12(1):205–218. doi: 10.1016/0896-6273(94)90164-3. [DOI] [PubMed] [Google Scholar]
  27. Verrijzer C. P., Van der Vliet P. C. POU domain transcription factors. Biochim Biophys Acta. 1993 Apr 29;1173(1):1–21. doi: 10.1016/0167-4781(93)90237-8. [DOI] [PubMed] [Google Scholar]
  28. Wegner M., Drolet D. W., Rosenfeld M. G. POU-domain proteins: structure and function of developmental regulators. Curr Opin Cell Biol. 1993 Jun;5(3):488–498. doi: 10.1016/0955-0674(93)90015-i. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES